These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7601562)

  • 1. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas.
    Kitahara K; Yasui W; Kuniyasu H; Yokozaki H; Akama Y; Yunotani S; Hisatsugu T; Tahara E
    Int J Cancer; 1995 Jul; 62(1):25-8. PubMed ID: 7601562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
    Marone M; Scambia G; Giannitelli C; Ferrandina G; Masciullo V; Bellacosa A; Benedetti-Panici P; Mancuso S
    Int J Cancer; 1998 Jan; 75(1):34-9. PubMed ID: 9426687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of G1-->S transition regulatory molecules in human urothelial cancer.
    Oya M; Schmidt B; Schmitz-Dräger BJ; Schulz WA
    Jpn J Cancer Res; 1998 Jul; 89(7):719-26. PubMed ID: 9738978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclins and Cdks on the cyclin B1 promoter activation.
    Moro A; Zerfass K; Joswig S; Jansen-Duerr P
    Biochem Mol Biol Int; 1997 Apr; 41(5):919-24. PubMed ID: 9137822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
    Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of cyclin genes in colorectal carcinomas.
    Leach FS; Elledge SJ; Sherr CJ; Willson JK; Markowitz S; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(9):1986-9. PubMed ID: 8481900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
    Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
    Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of cyclin E and cdk2 mRNAs at G1/S transition in Rat-1A cells emerging from the G0 state.
    Oda S; Nishida J; Nakabeppu Y; Sekiguchi M
    Oncogene; 1995 Apr; 10(7):1343-51. PubMed ID: 7731685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.
    Li JQ; Miki H; Ohmori M; Wu F; Funamoto Y
    Hum Pathol; 2001 Sep; 32(9):945-53. PubMed ID: 11567224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence.
    Kanazawa S; Fujiwara Y; Mizuno K
    Kobe J Med Sci; 1994 Dec; 40(5-6):165-74. PubMed ID: 7542356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
    Sui L; Tokuda M; Ohno M; Hatase O; Hando T
    Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
    Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
    Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
    Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells.
    Yamamoto H; Monden T; Miyoshi H; Izawa H; Ikeda K; Tsujie M; Ohnishi T; Sekimoto M; Tomita N; Monden M
    Int J Oncol; 1998 Aug; 13(2):233-9. PubMed ID: 9664116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.